Cardiac amyloidosis differential diagnosis: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Cardiac amyloidosis}} | {{Cardiac amyloidosis}} | ||
{{CMG}}; | {{CMG}}; {{AE}} {{RT}}; {{AN}}; {{LG}} | ||
== | ==Overview== | ||
[[Cardiomyopathy]] with [[congestive heart failure]] is the most common amyloidosis syndrome, especially in patients with no history of [[ischemia]] such as the presence of prior documented [[myocardial infarction]] or presence of [[coronary artery disease]] risk factors.<ref name="pmid10319082">{{cite journal |author=Gertz MA, Lacy MQ, Dispenzieri A |title=Amyloidosis: recognition, confirmation, prognosis, and therapy |journal=[[Mayo Clinic Proceedings. Mayo Clinic]] |volume=74 |issue=5 |pages=490–4 |year=1999 |month=May |pmid=10319082 |doi=10.4065/74.5.490 |url=http://linkinghub.elsevier.com/retrieve/pii/S0025-6196(11)65130-6 |accessdate=2012-02-13}}</ref> Cardiac amyloidosis should be included in the differential diagnoses in patients with [[congestive heart failure|unexplained congestive heart failure]] and no history of valvular disease, [[hypertension|long-standing hypertension]], or [[ischemia]].<ref name="pmid10319082">{{cite journal |author=Gertz MA, Lacy MQ, Dispenzieri A |title=Amyloidosis: recognition, confirmation, prognosis, and therapy |journal=[[Mayo Clinic Proceedings. Mayo Clinic]] |volume=74 |issue=5 |pages=490–4 |year=1999 |month=May |pmid=10319082 |doi=10.4065/74.5.490 |url=http://linkinghub.elsevier.com/retrieve/pii/S0025-6196(11)65130-6 |accessdate=2012-02-13}}</ref> | |||
==Differentiating Cardiac Amyloidosis from Other Diseases== | |||
==References== | ==References== | ||
Revision as of 17:10, 11 May 2013
|
Cardiac amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac amyloidosis differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Cardiac amyloidosis differential diagnosis |
|
Risk calculators and risk factors for Cardiac amyloidosis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]; Aarti Narayan, M.B.B.S [3]; Lakshmi Gopalakrishnan, M.B.B.S. [4]
Overview
Cardiomyopathy with congestive heart failure is the most common amyloidosis syndrome, especially in patients with no history of ischemia such as the presence of prior documented myocardial infarction or presence of coronary artery disease risk factors.[1] Cardiac amyloidosis should be included in the differential diagnoses in patients with unexplained congestive heart failure and no history of valvular disease, long-standing hypertension, or ischemia.[1]
Differentiating Cardiac Amyloidosis from Other Diseases
References
- ↑ 1.0 1.1 Gertz MA, Lacy MQ, Dispenzieri A (1999). "Amyloidosis: recognition, confirmation, prognosis, and therapy". Mayo Clinic Proceedings. Mayo Clinic. 74 (5): 490–4. doi:10.4065/74.5.490. PMID 10319082. Retrieved 2012-02-13. Unknown parameter
|month=ignored (help)